AKG supplement trial for older heart bypass patients
Part of Heart & circulation clinical trials.
This trial tests whether a supplement called alpha ketoglutarate (AKG) can help older adults recover better after heart bypass surgery. If you are 50 or older and scheduled for elective bypass surgery, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You are scheduled for elective coronary artery bypass graft (CABG) surgery that uses a heart-lung machine
- You are able to understand and agree to the study
- You are not already taking AKG supplements
- You do not have certain mental health conditions or an active infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking dietary supplements (like probiotics and omega-3) before and after coronary artery bypass surgery improves your recovery and overall health. If you are having CABG surgery, you may be randomly assigned to receive the supplements or standard care, and your progress will be tracked.
This trial tests whether taking a low dose of colchicine, an anti-inflammatory medicine, after heart bypass surgery can help keep the new blood vessels open and working well. It may help reduce the chance of the bypass grafts failing.
This study tests whether a daily supplement called AKG (alpha-ketoglutarate) can support brain health and thinking skills as we age. You would take the supplement for a period of time while researchers monitor your memory and overall well-being.
This trial tests a drug called EA-230 that may help people recover faster after heart bypass surgery. If you are having planned bypass surgery, this drug might shorten your hospital stay.
This trial tests whether combining two natural supplements (CoQ10 and glutathione) can protect your kidneys during heart bypass surgery. It may help prevent acute kidney injury, a common complication after these procedures.
This study tests a new way to connect a bypass graft during heart bypass surgery for people with blocked heart arteries. The goal is to see if the new graft can be safely placed and works well enough to improve outcomes compared with the standard approach.
Hear when a new CABG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.